| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |